![Simon Hesse Hoffmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Hesse Hoffmann
Direttore/Membro del Consiglio presso
AMBU A/S
Patrimonio netto: 22 M $ in data 31/08/2026
Profilo
Simon Hesse Hoffmann currently works at Nanovi Radiotherapy A, as Chairman, Magenta Capital UG (haftungsbeschränkt), as Chairman, Smil Fonden, as Vice Chairman, Ambu A, as Independent Director from 2022, 2cureX ApS, as Director from 2017, WireOnAir A, as Director, JHO Holding ApS, as Director, and Testa Invest ApS, as Director.
Mr. Hoffmann also formerly worked at HC Andersen Capital ApS, as Chairman and 2cureX AB, as Director from 2017 to 2019.
Mr. Hoffmann received his graduate degree from Copenhagen Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
AMBU A/S CLASS B 0,84% | 30/09/2025 | 1.985.000 ( 0,84% ) | 22 M $ | 31/08/2026 |
Posizioni attive di Simon Hesse Hoffmann
| Società | Posizione | Inizio |
|---|---|---|
| AMBU A/S | Direttore/Membro del Consiglio | 01/01/2022 |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Direttore/Membro del Consiglio | 01/01/2017 |
WireOnAir A/S | Direttore/Membro del Consiglio | - |
JHO Holding ApS
 JHO Holding ApS Financial ConglomeratesFinance Provides financial intermediation services | Direttore/Membro del Consiglio | - |
Nanovi Radiotherapy A/S
 Nanovi Radiotherapy A/S Medical SpecialtiesHealth Technology Operates as a medical device company that manufactures liquid fiducial markers to radiographically for cancer therapy | Presidente | - |
Magenta Capital UG (haftungsbeschränkt)
 Magenta Capital UG (haftungsbeschränkt) Miscellaneous Commercial ServicesCommercial Services Provides business and economic services | Presidente | - |
Precedenti posizioni note di Simon Hesse Hoffmann
| Società | Posizione | Fine |
|---|---|---|
| 2CUREX AB | Direttore/Membro del Consiglio | 02/04/2019 |
HC Andersen Capital ApS
 HC Andersen Capital ApS Investment ManagersFinance Provides investment research | Presidente | - |
Formazione di Simon Hesse Hoffmann
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
48
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Ambu A/S
 Ambu A/S Medical SpecialtiesHealth Technology Manufactures and markets diagnostic and life supporting devices for hospitals | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Health Technology |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Medical SpecialtiesHealth Technology Operates as a medical device company that manufactures liquid fiducial markers to radiographically for cancer therapy | Health Technology |
Magenta Capital UG (haftungsbeschränkt)
Magenta Capital UG (haftungsbeschränkt) Miscellaneous Commercial ServicesCommercial Services Provides business and economic services | Commercial Services |
2cureX AB
 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices | Health Technology |
WireOnAir A/S | |
JHO Holding ApS
JHO Holding ApS Financial ConglomeratesFinance Provides financial intermediation services | Finance |
HC Andersen Capital ApS
HC Andersen Capital ApS Investment ManagersFinance Provides investment research | Finance |
